Who owns the THERAVANCE BIOPHARMA trademark?

The THERAVANCE BIOPHARMA trademark is owned by Theravance Biopharma Ireland Limited.

What is the serial number for THERAVANCE BIOPHARMA?

The USPTO serial number for THERAVANCE BIOPHARMA is 79260681.

What is the registration number for THERAVANCE BIOPHARMA?

THERAVANCE BIOPHARMA is registered under USPTO registration number 6061018.

THE

USPTO Trademark Record

REGISTERED

THERAVANCE BIOPHARMA

Q: What class is the THERAVANCE BIOPHARMA trademark registered in?

The THERAVANCE BIOPHARMA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79260681·Reg 6061018·Filed Feb 08, 2019

Owner Theravance Biopharma Ireland Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

THERAVANCE BIOPHARMA (Serial No. 79260681), Registration No. 6061018, is a registered US trademark filed on Feb 08, 2019 by Theravance Biopharma Ireland Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

renewal grace 6y period: November 26, 202651 days remaining

Mark Intelligence

THERAVANCE BIOPHARMA (Reg. #6061018) is a registered US trademark that has been protecting its owner, Theravance Biopharma Ireland Limited, since 2019. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Feb 08, 2019

SERIAL

79260681

REG#

6061018

REGISTERED

May 26, 2020

Owner

Applicant

Theravance Biopharma Ireland Limited

Entity

Not Provided

Address

10 Earlsfort Terrace,, Dublin 2 D02 T380

Country

Attorney

NameBeth H. Alter

Law firm

Beth H. Alter Seward & Kissel LLP

Address

One Battery Park Plaza, New York, NY 10004, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 08, 2019

Serial Number79260681

Registration No.6061018

Registration DateMay 26, 2020

Status DateAug 31, 2026

Published for OppositionMar 10, 2020

Mark TypeStandard characters

Status DescriptionLive and registered, Section 71 and 15 accepted and acknowledged

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

30 events

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

Aug 31, 2026

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

Aug 31, 2026

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Aug 23, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 71 & 15 RECEIVED

May 18, 2026

TEAS SECTION 71 & 15 RECEIVED

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

May 26, 2025

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jul 23, 2023

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Oct 17, 2020

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Sep 24, 2020

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Sep 24, 2020

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Aug 26, 2020

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

May 26, 2020

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Mar 10, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 10, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Mar 07, 2020

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 19, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Feb 19, 2020

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Feb 19, 2020

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 05, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 07, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 06, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 06, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY IB

Aug 02, 2019

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jul 13, 2019

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 13, 2019

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jun 26, 2019

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jun 25, 2019

NON-FINAL ACTION WRITTEN

APPLICATION FILING RECEIPT MAILED

Jun 22, 2019

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 18, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ASSIGNED TO EXAMINER

Jun 18, 2019

ASSIGNED TO EXAMINER

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jun 13, 2019

SN ASSIGNED FOR SECT 66A APPL FROM IB

THERAVANCE BIOPHARMA

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Theravance Biopharma Ireland Limited

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Beth H. Alter

Resources

Company